[
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Company (BMY) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) 43rd Annual J.P.",
    "url": "https://finnhub.io/api/news?id=98912e5a40be03f4a5d61707b7802aee05e5875e94019a5088a7a2a0c357524d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736776823,
      "headline": "Bristol-Myers Squibb Company (BMY) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)",
      "id": 132389018,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) 43rd Annual J.P.",
      "url": "https://finnhub.io/api/news?id=98912e5a40be03f4a5d61707b7802aee05e5875e94019a5088a7a2a0c357524d"
    }
  },
  {
    "ts": null,
    "headline": "ArsenalBio and Bristol Myers Squibb Achieve Milestone for AB-4000 Series as Part of Ongoing Multi-Program Collaboration to Advance Next-Generation T Cell Therapies for Solid Tumors",
    "summary": "-- Bristol Myers Squibb exercises an exclusive license option for ArsenalBio’s AB-4000 series programs -- -- ArsenalBio is eligible for additional milestone payments and royalties as the programs...",
    "url": "https://finnhub.io/api/news?id=d061e5b70255e4e7a4bf76e6224aebbf686780c864d568c555b2ad0a154db78a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736751719,
      "headline": "ArsenalBio and Bristol Myers Squibb Achieve Milestone for AB-4000 Series as Part of Ongoing Multi-Program Collaboration to Advance Next-Generation T Cell Therapies for Solid Tumors",
      "id": 132386708,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "-- Bristol Myers Squibb exercises an exclusive license option for ArsenalBio’s AB-4000 series programs -- -- ArsenalBio is eligible for additional milestone payments and royalties as the programs...",
      "url": "https://finnhub.io/api/news?id=d061e5b70255e4e7a4bf76e6224aebbf686780c864d568c555b2ad0a154db78a"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Named to Dow Jones Sustainability Index North America for Second Consecutive Year",
    "summary": "PRINCETON, N.J. /3BL/ - Bristol Myers Squibb today announced that it has been named in the prestigious Dow Jones Sustainability Index for the second consecutive year. This recognition further...",
    "url": "https://finnhub.io/api/news?id=c342a8a594d11908db552353b80c549a81e1fc0e8e768d060c098e088786b5e3",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736738945,
      "headline": "Bristol Myers Squibb Named to Dow Jones Sustainability Index North America for Second Consecutive Year",
      "id": 132385672,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "PRINCETON, N.J. /3BL/ - Bristol Myers Squibb today announced that it has been named in the prestigious Dow Jones Sustainability Index for the second consecutive year. This recognition further...",
      "url": "https://finnhub.io/api/news?id=c342a8a594d11908db552353b80c549a81e1fc0e8e768d060c098e088786b5e3"
    }
  }
]